An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa. (Q53165661)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa. |
scientific article |
Statements
An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa. (English)
Pelekanou E
Antonopoulou A
Petropoulou H
Baziaka F
Karagianni V
Stavrianeas N
11 December 2007
158
3
567-572